GRoK Technologies LLC
GRoK Technologies is commercializing NASA life science discoveries in 3D human tissue engineering, regenerative medicine, stem cell technology & bioinformatics.
- Stage Full Product Ready
- Industry Biotechnology
- Location Houston, TX, US
- Currency USD
- Founded October 2011
- Employees 3
- Incorporation Type LLC
- Website groktechnologies.com
Company Summary
GRoK Technologies LLC is commercializing three decades of NASA life science R&D in 3D human tissue engineering, regenerative medicine, stem cell technology, and bioinformatics. Our human tissue engineering products and bioinformatics services aim to advance biologic and drug research and development, vaccine production, functional protein production, and regenerative medicine research and treatment.
Team
-
Chief Operating Officer
Joined GRoK in Dec-2015. 27 years in global pharmaceutical & biotechnology business/corporate/commercial development. 2011 to 2015 led corporate development, investor relations, alliance management and sales operations at VIVUS. Previously held senior executive, strategic planning/M&A and investor/public-facing roles at Capstone Therapeutics and Savient Pharmaceuticals. Began career at Wyeth-Ayerst Labs. MBA - Drexel University, Philadelphia.
-
Chief Executive Officer
Co-founded GRoK in 2011. 1998-2013 - senior tax partner in West Coast office of Skadden, Arps; M&A, cross-border transactions, financial products. 1986-1998 - law clerk, tax associate, Counsel to Tax Dept. Adjunct Prof., Tax, Loyola Law School, Los Angeles; Adjunct Prof., International Tax, Calif. St. U., Northridge; Chairman of Committee on Corporate Tax, LA County Bar Assoc.; Advisory Board Member, USC, Tax Institute. JD - Loyola; MBA - USC.
Advisors
-
Thomas J. Goodwin, Ph.D., (NASA, retired) - Chief Science & Technology AdvisorUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.